Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Reply: Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details

Désirée Deandreis, Martin Schlumberger and R. Michael Tuttle
Journal of Nuclear Medicine May 2017, 58 (5) 863-864; DOI: https://doi.org/10.2967/jnumed.117.190496
Désirée Deandreis
*Gustave Roussy 114 Rue Edouard Vaillant Villejuif, 94805, France E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: desiree.deandreis@gustaveroussy.fr
Martin Schlumberger
*Gustave Roussy 114 Rue Edouard Vaillant Villejuif, 94805, France E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: desiree.deandreis@gustaveroussy.fr
R. Michael Tuttle
*Gustave Roussy 114 Rue Edouard Vaillant Villejuif, 94805, France E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: desiree.deandreis@gustaveroussy.fr
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 5 863-864
DOI 
https://doi.org/10.2967/jnumed.117.190496
PubMed 
28232612

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 1, 2017.

Article Versions

  • previous version (February 23, 2017 - 04:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Reply: Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History
    Desiree Deandreis
    Journal of Nuclear Medicine 2017 58 9

Article usage

Article usage: February 2017 to April 2025

AbstractFullPdf
Feb 20171031
Mar 20170032
Apr 20171017
May 2017920689
Jun 201703418
Jul 20170429
Aug 20170195
Sep 201702410
Oct 201702312
Nov 20170106
Dec 20170176
Jan 201801110
Feb 20180125
Mar 2018084
Apr 20180144
May 2018074
Jun 201802427
Jul 2018036
Aug 20180102
Sep 2018094
Oct 20180247
Nov 20180392
Dec 20180135
Jan 20190127
Feb 2019063
Mar 2019096
Apr 2019074
May 2019063
Jun 2019073
Jul 2019083
Aug 2019073
Sep 2019072
Oct 20190117
Nov 20190136
Dec 2019031
Jan 2020092
Feb 2020052
Mar 20200139
Apr 20200114
May 20200114
Jun 20200103
Jul 2020051
Aug 20200104
Sep 20200114
Oct 2020084
Nov 20200111
Dec 2020044
Jan 2021061
Feb 202101118
Mar 20210252
Apr 20210164
May 20210108
Jun 20210122
Jul 20210106
Aug 2021096
Sep 2021098
Oct 20210926
Nov 202102012
Dec 20210134
Jan 2022087
Feb 2022071
Mar 2022073
Apr 2022068
May 2022037
Jun 2022074
Jul 2022093
Aug 2022074
Sep 20220810
Oct 20220119
Nov 2022070
Dec 2022011
Jan 2023094
Feb 2023070
Mar 2023095
Apr 20230112
May 2023058
Jun 2023010
Jul 20230145
Aug 2023019
Sep 2023098
Oct 2023021
Nov 20230511
Dec 2023091
Jan 2024031
Feb 2024063
Mar 20240529
Apr 2024077
May 20240192
Jun 20240158
Jul 2024078
Aug 2024098
Sep 2024057
Oct 2024087
Nov 2024095
Dec 2024073
Jan 20250169
Feb 20250295
Mar 20250168
Apr 202501222
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (5)
Journal of Nuclear Medicine
Vol. 58, Issue 5
May 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reply: Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reply: Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details
Désirée Deandreis, Martin Schlumberger, R. Michael Tuttle
Journal of Nuclear Medicine May 2017, 58 (5) 863-864; DOI: 10.2967/jnumed.117.190496

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reply: Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the Details
Désirée Deandreis, Martin Schlumberger, R. Michael Tuttle
Journal of Nuclear Medicine May 2017, 58 (5) 863-864; DOI: 10.2967/jnumed.117.190496
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Reply: Fixed 3.7-GBq 131I Activity for Metastatic Thyroid Cancer Therapy Ignores Science and History
  • Google Scholar

More in this TOC Section

  • Redefining Nuclear Medicine: “Biodistribution” Should Be the Core Concept
  • 176Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety
  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire